-
1
-
-
33846457870
-
Cancer statistics, 2007
-
Jemal A. Siegel R, Ward E, Murray T, Xu J, Tliun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57;43-66.
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Tliun, M.J.6
-
2
-
-
12944315020
-
Epithelial ovarian cancer: Prevention, diagnosis, and treatment
-
Partridge EE. Barnes MN. Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin 1999;49;297-320.
-
(1999)
CA Cancer J Clin
, vol.49
, pp. 297-320
-
-
Partridge, E.E.1
Barnes, M.N.2
-
3
-
-
0043240182
-
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
-
Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 2003;3:502-16.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 502-516
-
-
Agarwal, R.1
Kaye, S.B.2
-
4
-
-
18844432114
-
-
Ozols RF. Treatment goals in ovarian cancer. Int J Gynecol Cancer 20O5;15Suppl 1:3-11.
-
Ozols RF. Treatment goals in ovarian cancer. Int J Gynecol Cancer 20O5;15Suppl 1:3-11.
-
-
-
-
5
-
-
0036842215
-
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
-
Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368-80.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4368-4380
-
-
Dvorak, H.F.1
-
7
-
-
0030923795
-
Vascular endothelial growth factor expression in early stage ovarian carcinoma
-
Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997;80:98-106.
-
(1997)
Cancer
, vol.80
, pp. 98-106
-
-
Paley, P.J.1
Staskus, K.A.2
Gebhard, K.3
Mohanraj, D.4
Twiggs, L.B.5
Carson, L.F.6
Ramakrishnan, S.7
-
8
-
-
0028153737
-
Vascular permeability factor gene expression in normal and neoplastic human ovaries
-
Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994;54:276-80.
-
(1994)
Cancer Res
, vol.54
, pp. 276-280
-
-
Olson, T.A.1
Mohanraj, D.2
Carson, L.F.3
Ramakrishnan, S.4
-
9
-
-
0032742909
-
Tumor angiogenesis and recurrence in stage I non-small cell lung cancer
-
Ohta Y, Tomita Y, Oda M, Watanabe S, Murakami S, Watanabe Y. Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. Ann Thorac Surg 1999;68:1034-8.
-
(1999)
Ann Thorac Surg
, vol.68
, pp. 1034-1038
-
-
Ohta, Y.1
Tomita, Y.2
Oda, M.3
Watanabe, S.4
Murakami, S.5
Watanabe, Y.6
-
10
-
-
0031789314
-
Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
-
Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 1998;78:1379-84.
-
(1998)
Br J Cancer
, vol.78
, pp. 1379-1384
-
-
Ishigami, S.I.1
Arii, S.2
Furutani, M.3
Niwano, M.4
Harada, T.5
Mizumoto, M.6
Mori, A.7
Onodera, H.8
Imamura, M.9
-
11
-
-
0030817612
-
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopa-thology and patient survival, and analvsis of serum VEGF levels
-
Yaraamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Nanbu K, Sakahara H, Mori T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopa-thology and patient survival, and analvsis of serum VEGF levels. Br J Cancer 1997;76:1221-7.
-
(1997)
Br J Cancer
, vol.76
, pp. 1221-1227
-
-
Yaraamoto, S.1
Konishi, I.2
Mandai, M.3
Kuroda, H.4
Komatsu, T.5
Nanbu, K.6
Sakahara, H.7
Mori, T.8
-
12
-
-
0032944081
-
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonraalignant disease
-
Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Mamie D, Gastl G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonraalignant disease. Cancer 1999;85:178-87.
-
(1999)
Cancer
, vol.85
, pp. 178-187
-
-
Kraft, A.1
Weindel, K.2
Ochs, A.3
Marth, C.4
Zmija, J.5
Schumacher, P.6
Unger, C.7
Mamie, D.8
Gastl, G.9
-
13
-
-
0036793818
-
Preoperative serum vascular endothelial growth factor levels: Significance in ovarian cancer
-
Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 2002;8:3193-7.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3193-3197
-
-
Cooper, B.C.1
Ritchie, J.M.2
Broghammer, C.L.3
Coffin, J.4
Sorosky, J.I.5
Buller, R.E.6
Hendrix, M.J.7
Sood, A.K.8
-
14
-
-
0032787305
-
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-Rl-Fltl and VEGF-R2-Flkl/ KDR) in non-small cell lung carcinomas (NSCLCs): Correlation with angiogenesis and survival
-
Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-Rl-Fltl and VEGF-R2-Flkl/ KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J Pathol 1999;188:369-77.
-
(1999)
J Pathol
, vol.188
, pp. 369-377
-
-
Decaussin, M.1
Sartelet, H.2
Robert, C.3
Moro, D.4
Claraz, C.5
Brambilla, C.6
Brambilla, E.7
-
15
-
-
0032838197
-
Expression of vascular endothelial growth factor receptors in human prostate cancer
-
Ferrer FA, Miller LJ, Lindquist R, Kowalczyk P, Laudone VP, Albertsen PC, Kreutzer DL. Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology 1999;54: 567-72.
-
(1999)
Urology
, vol.54
, pp. 567-572
-
-
Ferrer, F.A.1
Miller, L.J.2
Lindquist, R.3
Kowalczyk, P.4
Laudone, V.P.5
Albertsen, P.C.6
Kreutzer, D.L.7
-
16
-
-
0035885932
-
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors
-
Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 2001;98:1904-13.
-
(2001)
Blood
, vol.98
, pp. 1904-1913
-
-
Masood, R.1
Cai, J.2
Zheng, T.3
Smith, D.L.4
Hinton, D.R.5
Gill, P.S.6
-
17
-
-
33747498714
-
The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma
-
Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S, Hicklin DJ. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Int J Cancer 2006; 119:1519-29.
-
(2006)
Int J Cancer
, vol.119
, pp. 1519-1529
-
-
Wu, Y.1
Hooper, A.T.2
Zhong, Z.3
Witte, L.4
Bohlen, P.5
Rafii, S.6
Hicklin, D.J.7
-
18
-
-
0034518226
-
Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor
-
Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroraa C, Falcinelli S, Zambruno G, D'Atri S. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol 2000;115:1000-7.
-
(2000)
J Invest Dermatol
, vol.115
, pp. 1000-1007
-
-
Lacal, P.M.1
Failla, C.M.2
Pagani, E.3
Odorisio, T.4
Schietroraa, C.5
Falcinelli, S.6
Zambruno, G.7
D'Atri, S.8
-
19
-
-
0033083962
-
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
-
Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999;59:728-33.
-
(1999)
Cancer Res
, vol.59
, pp. 728-733
-
-
Bellamy, W.T.1
Richter, L.2
Frutiger, Y.3
Grogan, T.M.4
-
20
-
-
0036468930
-
A potential autocrine role for vascular endothelial growth factor in prostate cancer
-
Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res 2002;62:854-9.
-
(2002)
Cancer Res
, vol.62
, pp. 854-859
-
-
Jackson, M.W.1
Roberts, J.S.2
Heckford, S.E.3
Ricciardelli, C.4
Stahl, J.5
Choong, C.6
Horsfall, D.J.7
Tilley, W.D.8
-
21
-
-
33745264885
-
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases
-
Lesslie DP. Summy JM, Parikli NU. Fan F. Trevino JG, Sawyer TK. Metcalf CA, Shakespeare WC, Hicklin DI, Ellis LM, Gallick GE. Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer 2006;94:1710-17.
-
(2006)
Br J Cancer
, vol.94
, pp. 1710-1717
-
-
Lesslie, D.P.1
Summy, J.M.2
Parikli, N.U.3
Fan, F.4
Trevino, J.G.5
Sawyer, T.K.6
Metcalf, C.A.7
Shakespeare, W.C.8
Hicklin, D.I.9
Ellis, L.M.10
Gallick, G.E.11
-
22
-
-
7244236494
-
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo
-
Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MA. Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Blood 2004;104:2893-902.
-
(2004)
Blood
, vol.104
, pp. 2893-2902
-
-
Wang, E.S.1
Teruya-Feldstein, J.2
Wu, Y.3
Zhu, Z.4
Hicklin, D.J.5
Moore, M.A.6
-
23
-
-
4444324696
-
VEGF, VEGFRs expressions and activated. STATs in ovarian epithelial carcinoma
-
Chen H, Ye D, Xie X, Chen B, Lu W. VEGF, VEGFRs expressions and activated. STATs in ovarian epithelial carcinoma. Gynecol Oncol 2004;94:630-5.
-
(2004)
Gynecol Oncol
, vol.94
, pp. 630-635
-
-
Chen, H.1
Ye, D.2
Xie, X.3
Chen, B.4
Lu, W.5
-
24
-
-
4444378842
-
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma
-
Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 2004; 101:1364 - 74.
-
(2004)
Cancer
, vol.101
, pp. 1364-1374
-
-
Nishida, N.1
Yano, H.2
Komai, K.3
Nishida, T.4
Kamura, T.5
Kojiro, M.6
-
25
-
-
0029929046
-
Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
-
Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest 1996;74:1105-15.
-
(1996)
Lab Invest
, vol.74
, pp. 1105-1115
-
-
Abu-Jawdeh, G.M.1
Faix, J.D.2
Niloff, J.3
Tognazzi, K.4
Manseau, E.5
Dvorak, H.F.6
Brown, L.F.7
-
26
-
-
27644479545
-
Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors
-
Thaker PH, Yazici S, Nilsson MB, Yokoi K, Tsan RZ, He J, Kim SJ, Fidler IJ, Sood AK. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. Clin Cancer Res 2005;11:4923-33.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4923-4933
-
-
Thaker, P.H.1
Yazici, S.2
Nilsson, M.B.3
Yokoi, K.4
Tsan, R.Z.5
He, J.6
Kim, S.J.7
Fidler, I.J.8
Sood, A.K.9
-
27
-
-
20944441857
-
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells
-
Fan F, Wey JS, McCarty MF, Belcheva A, Liu W, Bauer TW, Somcio RJ, Wu Y, Hooper A, Hicklin DJ, Ellis LM. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 2005;24:2647-53.
-
(2005)
Oncogene
, vol.24
, pp. 2647-2653
-
-
Fan, F.1
Wey, J.S.2
McCarty, M.F.3
Belcheva, A.4
Liu, W.5
Bauer, T.W.6
Somcio, R.J.7
Wu, Y.8
Hooper, A.9
Hicklin, D.J.10
Ellis, L.M.11
-
28
-
-
3042717667
-
Regulation of integrin-mediated cellular responses through assetnblv of a CAS/Crk scaffold
-
Chodniewicz D, Klemke RL. Regulation of integrin-mediated cellular responses through assetnblv of a CAS/Crk scaffold. Biochim Biophys Acta 2004;1692;63-76.
-
(2004)
Biochim Biophys Acta
, vol.1692
, pp. 63-76
-
-
Chodniewicz, D.1
Klemke, R.L.2
-
29
-
-
0032559562
-
-
Klemke RL, Leng J, Molander R, Brooks PC, Vuori K. Cheresh DA. CAS/Crk coupling serves as a molecular switch for induction of cell migration. J Cell Biol 1998;140:961-72.
-
Klemke RL, Leng J, Molander R, Brooks PC, Vuori K. Cheresh DA. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol 1998;140:961-72.
-
-
-
-
30
-
-
0037699007
-
CrkI adapter protein modulates cell migration and invasion in glioblastoma
-
Takino T, Nakada M, Miyamori H, Yamashita J, Yamada KM, Sato H. CrkI adapter protein modulates cell migration and invasion in glioblastoma. Cancer Res 2003;63:2335-7.
-
(2003)
Cancer Res
, vol.63
, pp. 2335-2337
-
-
Takino, T.1
Nakada, M.2
Miyamori, H.3
Yamashita, J.4
Yamada, K.M.5
Sato, H.6
-
31
-
-
84970070220
-
Expression of vascular endothelial growth factor and its receptor. KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
-
Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor. KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
-
(1995)
Cancer Res
, vol.55
, pp. 3964-3968
-
-
Takahashi, Y.1
Kitadai, Y.2
Bucana, C.D.3
Cleary, K.R.4
Ellis, L.M.5
-
32
-
-
0032146088
-
Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis
-
Fujimoto K, Hosotani R, Wada M, Lee JU, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S, Doi R, Imamura M. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer 1998;34:1439-47.
-
(1998)
Eur J Cancer
, vol.34
, pp. 1439-1447
-
-
Fujimoto, K.1
Hosotani, R.2
Wada, M.3
Lee, J.U.4
Koshiba, T.5
Miyamoto, Y.6
Tsuji, S.7
Nakajima, S.8
Doi, R.9
Imamura, M.10
-
33
-
-
0037386821
-
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer
-
Berns EM, Klijn JG, Look MP, Grebenchtchikov N, Vossen R, Peters H, Geurts-Moespot A, Portengen H, van Staveren IL, Meijer-van Gelder ME, Bakker B, Sweep FC, et al. Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. Clin Cancer Res 2003;9:1253-8.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 1253-1258
-
-
Berns, E.M.1
Klijn, J.G.2
Look, M.P.3
Grebenchtchikov, N.4
Vossen, R.5
Peters, H.6
Geurts-Moespot, A.7
Portengen, H.8
van Staveren, I.L.9
Meijer-van Gelder, M.E.10
Bakker, B.11
Sweep, F.C.12
-
34
-
-
0034772250
-
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480
-
George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. Clin Cancer Res 2001;7:1932-6.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1932-1936
-
-
George, D.J.1
Halabi, S.2
Shepard, T.F.3
Vogelzang, N.J.4
Hayes, D.F.5
Small, E.J.6
Kantoff, P.W.7
-
35
-
-
0141721698
-
-
Gorski DH, Leal AD, Goydos JS. Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma\ progression. J Am Coll Surg 2003;197:408-18.
-
Gorski DH, Leal AD, Goydos JS. Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma\ progression. J Am Coll Surg 2003;197:408-18.
-
-
-
-
36
-
-
0030921126
-
The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer
-
Nakanishi Y, Kodama J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H, Kudo T. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol 1997;16:256-62.
-
(1997)
Int J Gynecol Pathol
, vol.16
, pp. 256-262
-
-
Nakanishi, Y.1
Kodama, J.2
Yoshinouchi, M.3
Tokumo, K.4
Kamimura, S.5
Okuda, H.6
Kudo, T.7
-
37
-
-
0035845561
-
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
-
Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA, Rafii S, Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA 2001;98:10857-62.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 10857-10862
-
-
Dias, S.1
Hattori, K.2
Heissig, B.3
Zhu, Z.4
Wu, Y.5
Witte, L.6
Hicklin, D.J.7
Tateno, M.8
Bohlen, P.9
Moore, M.A.10
Rafii, S.11
-
38
-
-
0242331176
-
Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF
-
Endo A, Fukuhara S, Masuda M, Ohmori T, Mochizuki N. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF. J Recept Signal Transduct Res 2003;23:239-54.
-
(2003)
J Recept Signal Transduct Res
, vol.23
, pp. 239-254
-
-
Endo, A.1
Fukuhara, S.2
Masuda, M.3
Ohmori, T.4
Mochizuki, N.5
-
39
-
-
38449123004
-
Activation of the FAK-src molecular scaffolds and pl30Cas-JNK signaling cascades by alpha 1-integrins during colon cancer cell invasion
-
Van Slambrouck S, Grijelmo C, De Wever O, Bruyneel E, Emami S, Gespach C, Steelant WF. Activation of the FAK-src molecular scaffolds and pl30Cas-JNK signaling cascades by alpha 1-integrins during colon cancer cell invasion. Tnt J Oncol 2007;31:1501-8.
-
(2007)
Tnt J Oncol
, vol.31
, pp. 1501-1508
-
-
Van Slambrouck, S.1
Grijelmo, C.2
De Wever, O.3
Bruyneel, E.4
Emami, S.5
Gespach, C.6
Steelant, W.F.7
-
40
-
-
33746721000
-
Immunolocalizations of VEGF, its receptors fit-1, KDR and. TGF-beta's in epithelial ovarian tumors
-
Tnan S, Vatansever S, Celik-Ozenci C, Sanci M, Dicle N, Demir R. Immunolocalizations of VEGF, its receptors fit-1, KDR and. TGF-beta's in epithelial ovarian tumors. Histol Histopathol 2006;21:1055-64.
-
(2006)
Histol Histopathol
, vol.21
, pp. 1055-1064
-
-
Tnan, S.1
Vatansever, S.2
Celik-Ozenci, C.3
Sanci, M.4
Dicle, N.5
Demir, R.6
-
41
-
-
22244442697
-
Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines
-
Wey JS, Fan F, Grav MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 2005;104: 427-38.
-
(2005)
Cancer
, vol.104
, pp. 427-438
-
-
Wey, J.S.1
Fan, F.2
Grav, M.J.3
Bauer, T.W.4
McCarty, M.F.5
Somcio, R.6
Liu, W.7
Evans, D.B.8
Wu, Y.9
Hicklin, D.J.10
Ellis, L.M.11
-
42
-
-
36148987172
-
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
-
Dallas NA, Fan F, Gray MJ, Van Burnen G, II, Lira SJ, Xia L, Ellis LM. Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells. Cancer Metastasis Rev 2007;26:433-41.
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 433-441
-
-
Dallas, N.A.1
Fan, F.2
Gray, M.J.3
Van Burnen II, G.4
Lira, S.J.5
Xia, L.6
Ellis, L.M.7
-
43
-
-
62549135184
-
-
Camidge DR, Eckhardt SG, Diab S, Gore L, Chow L, O'Bryant C, Temmer E, Ervin-Haynes A, Kate T, Fox F, Cohen RB. A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG 1 monoclonal antibody (Mab). in patients (pts) with advanced cancer [abstract #3032]. J Clin Oncol 2006;24(18S)
-
Camidge DR, Eckhardt SG, Diab S, Gore L, Chow L, O'Bryant C, Temmer E, Ervin-Haynes A, Kate T, Fox F, Cohen RB. A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG 1 monoclonal antibody (Mab). in patients (pts) with advanced cancer [abstract #3032]. J Clin Oncol 2006;24(18S)
-
-
-
|